Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126963091 | 12696309 | 1 | I | 20160824 | 20160830 | 20160830 | EXP | CA-ROCHE-1819631 | ROCHE | 45.00 | YR | F | Y | 96.00000 | KG | 20160830 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126963091 | 12696309 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | FREQUENCY: CYCLICAL | U | 125085 | 960 | MG | SOLUTION FOR INFUSION | ||||||
| 126963091 | 12696309 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 2 | MG | ||||||||
| 126963091 | 12696309 | 3 | SS | DILANTIN | PHENYTOIN | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 126963091 | 12696309 | 4 | C | DIAMICRON | GLICLAZIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 126963091 | 12696309 | 5 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 126963091 | 12696309 | 6 | C | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
| 126963091 | 12696309 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | AS REQUIRED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126963091 | 12696309 | 1 | Glioblastoma |
| 126963091 | 12696309 | 2 | Glioblastoma |
| 126963091 | 12696309 | 3 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126963091 | 12696309 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126963091 | 12696309 | Amnesia | |
| 126963091 | 12696309 | Confusional state | |
| 126963091 | 12696309 | Diarrhoea | |
| 126963091 | 12696309 | Hypersensitivity | |
| 126963091 | 12696309 | Hypertension | |
| 126963091 | 12696309 | Malignant neoplasm progression | |
| 126963091 | 12696309 | Seizure | |
| 126963091 | 12696309 | Skin disorder | |
| 126963091 | 12696309 | Skin striae | |
| 126963091 | 12696309 | Skin ulcer | |
| 126963091 | 12696309 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |